Insulinoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
| Line 6: | Line 6: | ||
The predominant therapy for insulinoma is surgical resection. Supportive therapy for insulinoma includes octerotide, endoscopic ultrasound guided alcohol ablation, radiofrequency ablation, embolization, diazoxide and chemotherapy. | The predominant therapy for insulinoma is surgical resection. Supportive therapy for insulinoma includes octerotide, endoscopic ultrasound guided alcohol ablation, radiofrequency ablation, embolization, diazoxide and chemotherapy. | ||
==Medical Therapy== | ==Medical Therapy== | ||
The medical therapy of insulinoma include:<ref name="pmid23430217">{{cite journal| author=Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y et al.| title=Diagnosis and management of insulinoma. | journal=World J Gastroenterol | year= 2013 | volume= 19 | issue= 6 | pages= 829-37 | pmid=23430217 | doi=10.3748/wjg.v19.i6.829 | pmc=PMC3574879 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23430217 }} </ref><ref>[http://www.cancer.gov/cancertopics/pdq/treatment/isletcell/HealthProfessional/page6]</ref><ref>[http://www.nci.nih.gov/cancertopics/pdq/treatment/isletcell/Patient/page5]</ref> | The medical therapy of insulinoma include:<ref name="pmid23430217">{{cite journal| author=Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y et al.| title=Diagnosis and management of insulinoma. | journal=World J Gastroenterol | year= 2013 | volume= 19 | issue= 6 | pages= 829-37 | pmid=23430217 | doi=10.3748/wjg.v19.i6.829 | pmc=PMC3574879 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23430217 }} </ref><ref>Insulinoma. National cancer institute. [http://www.cancer.gov/cancertopics/pdq/treatment/isletcell/HealthProfessional/page6]</ref><ref>Insulinoma. National cancer institute. [http://www.nci.nih.gov/cancertopics/pdq/treatment/isletcell/Patient/page5]</ref> | ||
*[[Octreotide]] | *[[Octreotide]] | ||
*[[Endoscopic ultrasound]] guided alcohol ablation | *[[Endoscopic ultrasound]] guided alcohol ablation | ||
Revision as of 14:08, 15 October 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [4]
|
Insulinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Insulinoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Insulinoma medical therapy |
|
Risk calculators and risk factors for Insulinoma medical therapy |
Overview
The predominant therapy for insulinoma is surgical resection. Supportive therapy for insulinoma includes octerotide, endoscopic ultrasound guided alcohol ablation, radiofrequency ablation, embolization, diazoxide and chemotherapy.
Medical Therapy
The medical therapy of insulinoma include:[1][2][3]
- Octreotide
- Endoscopic ultrasound guided alcohol ablation
- Radiofrequency ablation (RFA)
- Embolization
- Diazoxide
- Combination chemotherapy
- Doxorubicin AND Streptozotocin
- Fluorouracil AND Streptozotocin (when doxorubicin is contraindicated)
References
- ↑ Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Ito S, Ogawa Y; et al. (2013). "Diagnosis and management of insulinoma". World J Gastroenterol. 19 (6): 829–37. doi:10.3748/wjg.v19.i6.829. PMC 3574879. PMID 23430217.
- ↑ Insulinoma. National cancer institute. [1]
- ↑ Insulinoma. National cancer institute. [2]